An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for Depression

Saved in:
Bibliographic Details
Main Authors: Katy H. Stimpson, T.J. Ford, Adi Maron-Katz, Michael Feyder, Danielle D. DeSouza, David Carreon, Eleanor J. Cole, Brandon S. Bentzley
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Brain Stimulation
Online Access:http://www.sciencedirect.com/science/article/pii/S1935861X25001895
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850036771911368704
author Katy H. Stimpson
T.J. Ford
Adi Maron-Katz
Michael Feyder
Danielle D. DeSouza
David Carreon
Eleanor J. Cole
Brandon S. Bentzley
author_facet Katy H. Stimpson
T.J. Ford
Adi Maron-Katz
Michael Feyder
Danielle D. DeSouza
David Carreon
Eleanor J. Cole
Brandon S. Bentzley
author_sort Katy H. Stimpson
collection DOAJ
format Article
id doaj-art-5075ec08357b45ca87396984848e5cf2
institution DOAJ
issn 1935-861X
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Brain Stimulation
spelling doaj-art-5075ec08357b45ca87396984848e5cf22025-08-20T02:57:04ZengElsevierBrain Stimulation1935-861X2025-07-011841315131610.1016/j.brs.2025.05.085An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for DepressionKaty H. Stimpson0T.J. Ford1Adi Maron-Katz2Michael Feyder3Danielle D. DeSouza4David Carreon5Eleanor J. Cole6Brandon S. Bentzley7Magnus Medical, Inc., Burlingame, CA, USAMagnus Medical, Inc., Burlingame, CA, USAMagnus Medical, Inc., Burlingame, CA, USAMagnus Medical, Inc., Burlingame, CA, USAAcacia Clinics, Sunnyvale, CA, USAAcacia Clinics, Sunnyvale, CA, USAMagnus Medical, Inc., Burlingame, CA, USAMagnus Medical, Inc., Burlingame, CA, USA; Corresponding authorhttp://www.sciencedirect.com/science/article/pii/S1935861X25001895
spellingShingle Katy H. Stimpson
T.J. Ford
Adi Maron-Katz
Michael Feyder
Danielle D. DeSouza
David Carreon
Eleanor J. Cole
Brandon S. Bentzley
An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for Depression
Brain Stimulation
title An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for Depression
title_full An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for Depression
title_fullStr An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for Depression
title_full_unstemmed An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for Depression
title_short An Open-Label Pilot Trial to Assess the Feasibility of Using the Magnus Neuromodulation System with Stanford Accelerated Intelligent Neuromodulation Therapy (SAINTⓇ) as a Personalized Continuation Therapy for Depression
title_sort open label pilot trial to assess the feasibility of using the magnus neuromodulation system with stanford accelerated intelligent neuromodulation therapy saintⓡ as a personalized continuation therapy for depression
url http://www.sciencedirect.com/science/article/pii/S1935861X25001895
work_keys_str_mv AT katyhstimpson anopenlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT tjford anopenlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT adimaronkatz anopenlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT michaelfeyder anopenlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT danielleddesouza anopenlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT davidcarreon anopenlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT eleanorjcole anopenlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT brandonsbentzley anopenlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT katyhstimpson openlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT tjford openlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT adimaronkatz openlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT michaelfeyder openlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT danielleddesouza openlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT davidcarreon openlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT eleanorjcole openlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression
AT brandonsbentzley openlabelpilottrialtoassessthefeasibilityofusingthemagnusneuromodulationsystemwithstanfordacceleratedintelligentneuromodulationtherapysaintasapersonalizedcontinuationtherapyfordepression